Moderna (MRNA) stock price shows potential for a reversal near the $120 support level. If the stock remains above this critical support, it is highly likely to reach a target range of $185 to $200 by the end of the year.
Penafian
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Penafian
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.